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Abstract
Background: Differences in duration of bone healing in various parts of the human skeleton are
common experience for orthopaedic surgeons. The reason for these differences is not obvious and
not clear.
Methods: In this paper we decided to measure by the use of real-time RT-PCR technique the level
of expression of genes for some isoforms of bone morphogenetic proteins (BMPs), whose role is
proven in bone formation, bone induction and bone turnover. Seven bone samples recovered from
various parts of skeletons from six cadavers of young healthy men who died in traffic accidents
were collected. Activity of genes for BMP-2, -4 and -6 was measured by the use of fluorescent SYBR
Green I.
Results: It was found that expression of m-RNA for BMP-2 and BMP-4 is higher in trabecular bone
in epiphyses of long bones, cranial flat bones and corpus mandibulae then in the compact bone of
diaphyses of long bones. In all samples examined the expression of m-RNA for BMP-4 was higher
than for BMP-2.
Conclusion: It was shown that m-RNA for BMP-6 is not expressed in the collected samples at all.
It is postulated that differences in the level of activation of genes for BMPs is one of the important
factors which determine the differences in duration of bone healing of various parts of the human
skeleton.
Background
Bone mass is a changeable parameter. Its peak is reached
in the age of 30–35 years. Bone turnover is under the con-
trol of two cell populations – osteoblasts and osteoclasts.
These cells are influenced by many factors which control
the balance of bone formation and bone resorption. The
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same cell populations and factors are active in bone heal-
ing. Bone morphogenetic proteins (BMPs) are involved in
many processes which take place in bone formation, bone
induction, and bone regeneration as e.g. callus formation
in the course of bone healing. The full picture of bone
turnover is not completed as yet, although many factors
and interactions are well described. The complexity of
bone turnover involves the long list of about 200 factors
influencing each other in various physiological and/or
pathological situations. PTGF (platelet derived growth
factor) and TGF-β (transforming growth factor – beta)
together with the BMPs are the most important factors in
the process of bone healing. The new research [1] data
make the situation even more complex.
Differences in the dynamic of bone healing in various
parts of skeleton are well documented in literature. In
population of healthy people the cortical bone heals
within 4–8 months, and trabecular bone in 3–6 months.
The healing of cranial bones can take from several weeks
to 5 years. Broken mandible heals normally during 3–4
weeks. It takes several months for healing of broken bones
of pelvis. Broken humeri are healed in 3–6 months. Simi-
lar time is needed for healing of femurs. Complexity of
orthopaedic situation has important influence on time of
bone repair [2-7].
BMPs play very important role in bone physiology influ-
encing bone growth, turnover, bone formation and carti-
lage induction [8]. Their influence is not restricted to bone
tissue. BMPs regulate apoptosis in various types of tissues
[9,10]. It seems that the study of some BMPs isoforms
reveals unexpected and very important activities of these
proteins. In one of the recent publication by the group of
Vescovi it was shown that the BMP-4 elicits strongest
effect in triggering a significant reduction in tumor-initiat-
ing precursors of human glioblastoma [11]. All BMPs,
except BMP-1, belong to the superfamily of transforming
growth factors β, forming large group of signaling mole-
cules [10,12-15]. Their activity is related only to dimeric
form. Both homodimers as well as heterodimers are active
[13,16], although their biological activity differs [14].
High activity of heterodimers BMP-4–7 and BMP-2–7 was
established in vitro and in vivo [13]. High osteoinductive
potency was proved for heterodimers BMP-2–6 in com-
parison with respective homodimers [17,18]. In bone
matrix BMPs are connected with collagen and are not
active unless released by the action of collagenases of oste-
oclasts [14].
According to the literature [19] BMPs -2, -4, -6 exert high
osteoinductive potential, influencing odontogenesis
[10,19-21], bone regeneration and healing [13,22-27],
bone formation [15,17,28-31] and heterotopic bone
induction [32-34]. In tissue culture BMPs are needed for
formation of osteogenic cell lines [13,32,34,35].
The aim of this paper is to show that, in spite of incom-
plete knowledge of the mechanisms of bone homeostasis,
some important differences exist at the molecular level,
which can explain the differences in the dynamic of heal-
ing of distinct parts of human skeleton. By the use of
quantitative real-time RT-PCR we were able to show the
differences in the level of expression of some isoforms of
BMPs in various bones or their parts.
The results were confirmed by the analysis of the electro-
phoretic bands.
Methods
Tissue samples and total RNA isolation and quantification
Forty two biopsies of normal bone tissue taken post mor-
tem from six cadavers of young healthy men who died in
traffic accidents were frozen. Biopsies were taken from
seven different bones. The cadavers are treated as "young
healthy" after the routine serology done for all tissue bank
donors. Biopsies (5–7 cm long and 2–3 cm wide) were
taken from seven different bones. Bone marrow was
removed from trabecular bone by the routine technique
used in our bone bank. There were: cranial flat bones, cor-
pus mandibulae, diaphysis radii, distal epiphysis radii, ala
ossis ilii, diaphysis femoris and distal epiphysis femoris.
Total RNA was extracted using TRIzol Reagent (GIBCO
BRL) according to manufacturer's recommendations. Fro-
zen in liquid nitrogen and physically powdered bone
(200 mg) was suspended in 1 ml of TRIzol Reagent, vor-
texed and incubated 30 min at room temperature with
continuous horizontal rotation. The RNA pellet was dis-
solved in 20–30 µl of sterile diethylpyrocarbonate-treated
Mili-Q water and quantified spectrophotometrically at
260 nm. The quality of the extracted RNAs was verified by
agarose gel electrophoresis. RNAs were stored as a water
solution at -70°C. The "donors" were transported after
accidents to the Dept. of Forensic Medicine and located
for the night in cold compartments. The samples were col-
lected in the morning after medico-legal section and fro-
zen in dry ice. We never attempted the investigation on
degradation of beta-actin or BMPs – mRNAs as a function
of time.
Reverse transcription
Single stranded complementary DNA (cDNA) was synthe-
sized with oligo(dT)12–18 primers from 5 µg of total RNA
using SUPERSCRIPT First-Strand Synthesis System for RT-
PCR (GIBCO BRL) accordingly to the manufacturer's
instruction.BMC Musculoskeletal Disorders 2007, 8:128 http://www.biomedcentral.com/1471-2474/8/128
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Quantitation of BMPs expression by real-time PCR
Accumulation of PCR products was measured in real-time
by using QuantiTect SYBR Green PCR Kit (Qiagen). The
sequences of primers are listed in Table 1. Reaction was
performed in DNA Engine Opticon® 2 Real-Time Detec-
tion System (MJ Research) three times for each probe
starting with 10 – 15 min of preincubation at 94°C fol-
lowed by 45 amplification cycles as follows: 94°C for 1
min, annealing temperature for 1 min and 72°C for 1
min. Beta-actin was used as housekeeping gene for arbi-
trary unit calculation for every tested gen. Additionally
product identity was confirmed by electrophoresis on a
1.7% agarose (GIBCO BRL) gel and visualized by ethid-
ium bromide (SIGMA) staining under UV light.
Statitistics: All statistical analysis was performed using the
STATISTICA 5.0 software (StatSoft, Inc., STATISTICA for
Windows, Tulsa, OK). We compared the analysed groups
using the analysis of variance (ANOVA). Levels of statisti-
cal significance was set as p = 0,05: S-significant difference
(p < = 0,05), NS – no statistical difference was found (p >
0,05).
Results
Real-time PCR technique was very useful for detection,
determination and comparison of three BMP isoforms
expressions. The use of β-actin gene expression as a house-
keeping gene allowed for calculation of arbitrary units
and for comparison of BMP-2, BMP-4 and BMP-6 genes
expression not only between them but also between dif-
ferent types of bones. Obtained results showed significant
expression of two isoforms of these proteins – BMP-2 and
BMP-4 (Figures 1 and 2, respectively). Expression of BMP-
6 was not detected. Melting temperatures of amplicons
demonstrate their specifity (Figure 3) and electrophoretic
analysis proved identity of these products (Figures 4 and
5). This multi-analysis allowed for conclusions that there
is no BMP-6 gene expression in all examined bone sam-
ples.
Discussion
In this paper we demonstrated the differences in expres-
sion of m-RNA for isoforms BMP-2, BMP-4 in various
parts of the human skeleton (Table 2).
These differences concerned expression of m-RNAs for
genes BMP-2 and BMP-4. In the same bone sample the
level of expression of m-RNAs for BMP-2 and BMP-4 dif-
fer. These differences are significant when compact bone
and trabecular bone are compared.
Results of descriptive statistics (Fig 1) show that expres-
sion of m-RNA for BMP-2 is higher in ala ossis illi, and in
trabecular bone of epiphyses of long bones as well as of
flat bones then in corpus mandibulae and in the compact
bone of diaphyses of long bones (Fig 1). The level of
expression of BMP-4 is higher in trabecular bone in epi-
physes of long bones, ala ossis illi and corpus mandibulae
then in the compact bone of diaphyses of long bones and
cranial flat bones (Fig 2).
In all examined samples the level of expression of m-RNA
for BMP-4 was higher than for BMP-2 (Fig. 1 and Fig. 2).
Several repetitions of measurements by real-time RT-PCR
excluded expression of mRNA for BMP-6 in analysed sam-
ples.
Comparison of BMP-2 expression levels in separate bone  groups Figure 1
Comparison of BMP-2 expression levels in separate bone 
groups. Box plot graph, Mean, SE – Standard error, SD – 
Standard Deviation.
Table 1: Primer sequences and sizes of amplicons generated by Real-time RT-PCR
mRNA Forward primer (5'-3') Reverse primer (5'-3') Annealing [°C] Amplicon [bp] Accession number Citation
BMP-2 ATGGATTCGTGGTGGAAGTG GTGGAGTTCAGATGATCAGC 58 349 NM_001200.2 [41]
BMP-4 AGCATGTCAGGATTAGCCGA TGGAGATGGCACTCAGTTCA 58 399 NM_130851.1 [41]
BMP-6 CAGCCTGCAGGAAGCATGAG CAAAGTAAAGAACCGAGATG 53 246 NM_001718.2 [42]
β-actin GGGTCAGAAGGATTCCTATG GGTCTCAAACATGATCTGGG 58 237 NM_001101.2 [43]BMC Musculoskeletal Disorders 2007, 8:128 http://www.biomedcentral.com/1471-2474/8/128
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Our results differ from the ones which were published by
the Thailand group [36]. We are not fully convinced by
their results. They used the semiquantitative technique of
RT-PCR and the measurements were based on the inten-
sity of fluorescence of the agarose gels standardized
against cDNA for control gene for GAPDH (glyceralde-
hyde-3-phosphate dehydrogenase). Their samples were
taken from patients in the course of surgery and it is diffi-
cult to call them "normal control samples". In the healing
bones after fracture, activation of BMP-6 gene is expected.
Literature data [28,37,38] allow us to assume, that the
lack of m-RNA for BMP-6 in all our samples was compen-
sated by activity of BMP-2 [28]. Because of the high oste-
ogenic activity of homodimers BMP-2/BMP-2 and BMP-4/
BMP-4 and of high probability of formation of het-
erodimers BMP-2/BMP-4, the lack of BMP-6 can be
explained by the substitution by homodimers BMP-2/
BMP-4. The additional argument for our reasoning is the
high identity in sequence of proteins BMP-2 and BMP-4
reaching 92% [10,13,39,40]. Both belong to the same
subclass, in contrast to BMP-6, which is the member of
different subfamily.
Conclusion
The analysis of various parts of skeleton of six healthy
men who died in traffic accidents showed several differ-
ences in expression of some BMPs- isoforms as measured
by real-time RT-PCR spectrometry:
1. Various bones forming the skeleton differ in the level of
expression of BMP-2 and BMP-4 isoforms.
2. Significant differences were found in expression of
BMP-2 between cranial flat bones and ala ossis ilii, corpus
mandibulae and ala ossis ilii, diaphysis radii and ala ossis
ilii, diaphysis femoris and distal epiphysis femoris (Table
3, Figure 1)
3. Significant differences were found in expression of
BMP-4 between cranial flat bones and ala ossis ilii, cranial
flat bones and distal epiphysis radii, corpus mandibulae
and distal epiphysis radii, diaphysis and distal epiphysis
radii, diaphysis radii and ala ossis ilii, diaphysis radii and
ala ossis ilii, distal epiphysis radii and ala ossis ilii, distal
epiphysis radii and diaphysis femoris, ala ossis ilii and
diaphysis femoris, diaphysis and distal epiphysis femoris.
(Table 4, Figure 2).
4. Significant differences exist in the mean values of the
levels of expression of BMP-2 when compared with the
level of BMP-4 between the following parts of skeletons:
diaphysis radii, distal epiphysis radii, ala ossis ilii, and dis-
tal epiphysis femoris (Table 5).
5. In all other measured parts of skeleton the levels of
expression of the two isoforms of BMP were similar and
did not differ significantly.
6. The expression of BMP-6 isoform was not found in all
examined samples.
The obtained results might help to understand the differ-
ences in the speed of healing of various parts of the skele-
ton. We have started the measurements of samples of
callus obtained in the course of surgical revisions of slow
healing bone fractures.
The obtained results might also have some value for the
bone banks where the level of expression of BMPs could
change after single steps of bone preservation as freezing,
liophilisation, radiation sterilization etc. The expected
role of bone implants prepared in bone banks is the pro-
motion of bone healing by two processes – conduction
and induction.
The process of bone induction in human orthopaedic
practice is not well documented.
Some bone banks try to promote this ability by adding
synthetic recombined BMPs to bone implants, sometimes
with the addition of hydroxyapatite. This is why the
knowledge of bioinductive properties of single parts of
skeleton is important.
Competing interests
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Comparison of BMP-4 expression levels in separate bone  groups Figure 2
Comparison of BMP-4 expression levels in separate bone 
groups. Box plot graph, Mean, SE – Standard error, SD – 
Standard Deviation.BMC Musculoskeletal Disorders 2007, 8:128 http://www.biomedcentral.com/1471-2474/8/128
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Expression of BMPs in different bone biopsies derived from 6 patients quantified by real-time PCR Figure 3
Expression of BMPs in different bone biopsies derived from 6 patients quantified by real-time PCR.
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Melting curves of real-time PCR products Figure 4
Melting curves of real-time PCR products.
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Electrophoretic analysis of real-time PCR products Figure 5
Electrophoretic analysis of real-time PCR products.
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Table 2: The number and codes of examined skeletal bone samples
Group Name Group Code N
BMP – 2 BMP – 4
Cranial flat bones Bone 1 18 18
Corpus mandibulae Bone 2 18 18
Diaphysis radii Bone 3 18 18
Distal epiphysis radii Bone 4 18 18
Ala ossis ilii Bone 5 18 18
Diaphysis femoris Bone 6 18 18
Distal epiphysis femoris Bone 7 18 18
Table 3: Evaluation of significant differences between mean levels of BMP-2 expression in all examined bones. S – significant difference 
(p < = 0,05); NS – no statistical difference was found (p > 0,05)
Bone 1 Bone 2 Bone 3 Bone 4 Bone 5 Bone 6 Bone 7
Bone 1 - NS NS NS S NS NS
B o n e  2 N S-N S N SSN S N S
B o n e  3 N S N S-N SSN S N S
Bone 4 NS NS NS - NS NS NS
Bone 5 S S S NS - S NS
Bone 6 NS NS NS NS S - NS
B o n e  7 N SN SN SN SN SN S -
Table 4: Evaluation of significant differences between mean levels of BMP-4 expression in all examined bones. S – significant difference 
(p < = 0,05); NS – no statistical difference was found (p > 0,05)
Bone 1 Bone 2 Bone 3 Bone 4 Bone 5 Bone 6 Bone 7
Bone 1 - NS NS S S NS NS
B o n e  2 N S - N S S N SN SN S
Bone 3 NS NS - S S NS NS
B o n e  4 SSS-SS N S
Bone 5 S NS S S - S NS
B o n e  6 N SN SN S S S - S
B o n e  7 N SN SN SN SN S S -
Table 5: The results of the comparison by the Analysis of Variance (ANOVA) (p = 0,05) of the mean levels of expression of BMP-2 and 
the levels of BMP-4 in the groups of examined bones. S – significant difference (p < = 0,05); NS – no statistical difference was found (p > 
0,05)
Mean BMP-2 Mean BMP-4 Std. Dev. BMP-2 Std. Dev. BMP-4 Valid N BMP-2 Valid N BMP-4 F p
Bone 1 NS 90,7208 94,3128 7,6504 9,4994 18 18 1,5610 0,2200
Bone 2 NS 89,7981 98,2081 10,4187 14,2636 18 18 4,0804 0,0513
Bone 3 S 89,6294 97,0668 6,2952 10,1941 18 18 6,9357 0,0126
Bone 4 S 93,3007 106,2281 10,4861 8,3981 18 18 16,6666 0,0002
Bone 5 S 95,6507 102,5552 9,4378 9,2962 18 18 4,8896 0,0338
Bone 6 NS 89,5953 91,8471 8,7169 10,1045 18 18 0,5124 0,4789
Bone 7 S 92,2981 100,2836 8,0808 12,6990 18 18 5,0663 0,0309BMC Musculoskeletal Disorders 2007, 8:128 http://www.biomedcentral.com/1471-2474/8/128
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